Kimryn Rathmell, MD, PhD, on ASCO's New Guidelines for Metastatic Clear Cell RCC - Medpage Today
8/1/2022 12:00:00 AM3 years 7 months ago
by Jeff Minerd;
by Jeff Minerd;
New treatments led to first comprehensive recommendations for most common kidney cancer subtype
ASCO recently published its first comprehensive guidelines for treating metastatic clear cell renal cell carcinoma (ccRCC). This disease is the most common subtype, and it continues to be a major so… [+4335 chars]
full article...